留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

重视老年高血压的调控与管理

李玲 方理刚

李玲, 方理刚. 重视老年高血压的调控与管理[J]. 协和医学杂志, 2019, 10(2): 112-116. doi: 10.3969/j.issn.1674-9081.2019.02.005
引用本文: 李玲, 方理刚. 重视老年高血压的调控与管理[J]. 协和医学杂志, 2019, 10(2): 112-116. doi: 10.3969/j.issn.1674-9081.2019.02.005
Ling LI, Li-gang FANG. Pay Attention to the Treatment and Management of Hypertension in the Elderly[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(2): 112-116. doi: 10.3969/j.issn.1674-9081.2019.02.005
Citation: Ling LI, Li-gang FANG. Pay Attention to the Treatment and Management of Hypertension in the Elderly[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(2): 112-116. doi: 10.3969/j.issn.1674-9081.2019.02.005

重视老年高血压的调控与管理

doi: 10.3969/j.issn.1674-9081.2019.02.005
详细信息
    通讯作者:

    方理刚 电话:010-69155067,E-mail:fanglgpumch@sina.com

  • 中图分类号: R544.1

Pay Attention to the Treatment and Management of Hypertension in the Elderly

More Information
  • 摘要: 伴随我国人口老龄化进程加速,老年高血压患者的数量逐年增加。目前通常情况下,年龄≥65岁的高血压患者被定义为老年高血压。与中青年高血压患者相比,老年高血压患者的发病机制、临床表现具有特殊性,患者心脑血管事件显著增加。老年高血压多表现为单纯收缩期高血压、脉压增大、血压易波动、合并疾病多等特点,与年轻患者相比降压治疗的难度增加。老年高血压的治疗目的是保护靶器官、减少心脑血管事件,但老年人的降压获益与患者治疗耐受性以及降压治疗的潜在危害相关,在治疗时应选择个体化治疗方案并全面评估和密切监测患者情况,平稳降压,其降压目标可设为<150/90 mm Hg(1 mm Hg=0.133 kPa)。
    利益冲突  无
  • 表  1  国内外不同高血压防治指南中的降压目标

    指南 降压目标
    JNC 8[17] ≥60岁,<150/90 mm Hg
    2017 ACC/AHA高血压指南[15] ≥65岁,有活动能力的老年人,收缩压<130 mm Hg
    老年高血压的诊断与治疗中国专家共识(2017年版)[10] ≥65岁,<150/90 mm Hg,若能耐受可降至140/90 mm Hg以下
    2018 ESC/ESH高血压指南[16] ≥65岁,若能耐受,收缩压130~139mm Hg,舒张压70~79mm Hg
    中国高血压防治指南2018年修订版[5] 65~79岁,首先降至<150/90 mm Hg,若能耐受可降至<140/90 mm Hg; ≥80岁,降至<150/90 mm Hg
    JNC:美国预防、检测、评估与治疗高血压全国联合委员会;ACC/AHA:美国心脏病学会/美国心脏协会;ESC/ESH:欧洲心脏病学会/欧洲高血压学会
    下载: 导出CSV
  • [1] 中国居民营养与健康状况调查技术执行组.中国居民2002年营养与健康状况调查[J].中华流行病学杂志, 2005, 26:478-484. doi:  10.3760/j.issn:0254-6450.2005.07.004
    [2] Williamson JD, Supiano MA, Applegate WB, et al. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: a Randomized Clinical Trial[J]. JAMA, 2016, 315:2673-2682. doi:  10.1001/jama.2016.7050
    [3] Wright JT Jr, Williamson JD, Whelton PK, et al. A randomized trial of intensive versus standard blood-pressure control[J]. N Engl J Med, 2015, 373:2103-2116. doi:  10.1056/NEJMoa1511939
    [4] Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age older[J]. N Engl J Med, 2008, 358:1887-1898. doi:  10.1056/NEJMoa0801369
    [5] 中国高血压防治指南修订委员会.中国高血压防治指南2018年修订版[M].北京: 中国医药科技出版社, 2018.
    [6] 中国降压治疗预防卒中再发研究协作组.脑血管病患者脉压水平与脑卒中再发关系[J].中国循环杂志, 2003, 18:284-287. doi:  10.3321/j.issn:1000-3614.2003.04.014
    [7] Yu D, Simmons D. Association between pulse pressure and risk of hospital admissions for cardiovascular events among people with Type 2 diabetes: a population-based case-control study[J]. Diabet Med, 2015, 32:1201-1206. doi:  10.1111/dme.12693
    [8] Wang JG, Staessen JA, Gong L, et al. Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertension in China(Syst-China) Collaborative Group[J]. Arch Intern Med, 2000, 160:211-220. doi:  10.1001/archinte.160.2.211
    [9] 中华医学会老年医学分会, 中国医师协会高血压专业委员会.老年人高血压特点与临床诊治流程专家建议[J].中华老年医学杂志, 2014, 33:689-701. doi:  10.3760/cma.j.issn.0254-9026.2014.07.001
    [10] 中国老年学和老年医学会心脑血管病专业委员会, 中国医师协会心血管内科医师分会.老年高血压的诊断与治疗中国专家共识(2017版)[J].中华内科杂志, 2017, 56:885-893. doi:  10.3760/cma.j.issn.0578-1426.2017.11.00.024
    [11] Benetos A, Bulpitt CJ, Petrovic M, et al. An expert opinion from the European Society of Hypertension European Union Geriatric Medicine Society Working Group on the Management of Hypertension in very old, frail subjects[J]. Hypertension, 2016, 67:820-825. doi:  10.1161/HYPERTENSIONAHA.115.07020
    [12] Materson BJ, Garcia-Estrada M, Preston RA. Hypertension in the frail elderly[J]. J Am Soc Hypertens, 2016, 10:536-541. doi:  10.1016/j.jash.2016.03.187
    [13] Gong L, Zhang W, Zhu Y, et al. Shanghai trial of nifedipine in the elderly(STONE)[J]. J Hypertens, 1996, 14:1237-1245. doi:  10.1097/00004872-199610000-00013
    [14] Nerenberg KA, Zarnke KB, Leung AA, et al. Hypertension Canada's 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children[J]. Can J Cardiol, 2018, 34:506-525. doi:  10.1016/j.cjca.2018.02.022
    [15] Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/ AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ ASPC/NMA/ PCNA Guideline for the Prevention, Evaluation, and Management of High Blood pressure in Adults: A Report of the American of Cardiology/American Heart Association Task Force on Clinical Practice Guideline[J]. J AM Coll Cardiol, 2018, 71:2199-2269. doi:  10.1016/j.jacc.2017.11.005
    [16] Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the managenment of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension[J]. J Hypertens, 2018, 36:1953-2041. doi:  10.1097/HJH.0000000000001940
    [17] James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)[J]. JAMA, 2014, 311:507-520. doi:  10.1001/jama.2013.284427
    [18] 胡大一, 刘力生, 余金明, 等.中国门诊高血压患者治疗现状登记研究[J].中华心血管病杂志, 2010, 38:230-238. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhxxgb201003007
    [19] Bulpitt CJ, Beckett NS, Peters R, et al. Blood pressure control in the Hypertension in the Very Elderly Trial (HYVET)[J]. J Hum Hypertens, 2012, 26:157-163. doi:  10.1038/jhh.2011.10
    [20] Leung AA, Daskalopoulou SS, Dasgupta K, et al. Hypertension Canada's 2017 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults[J]. Can J Cardiol, 2017, 33:557-576. doi:  10.1016/j.cjca.2017.03.005
  • 加载中
表(1)
计量
  • 文章访问数:  614
  • HTML全文浏览量:  107
  • PDF下载量:  310
  • 被引次数: 0
出版历程
  • 收稿日期:  2018-12-03
  • 刊出日期:  2020-09-18

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!